Literature DB >> 16365361

Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin.

D Roy, J Quiles, D C Gaze, P Collinson, J C Kaski, G F Baxter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16365361      PMCID： PMC1861004          DOI： 10.1136/hrt.2004.049643

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  6 in total

1.  The search for a biomarker of cardiac ischemia.

Authors:  David A Morrow; James A de Lemos; Marc S Sabatine; Elliott M Antman
Journal:  Clin Chem       Date:  2003-04       Impact factor: 8.327

2.  Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I.

Authors:  D Bar-Or; J V Winkler; K Vanbenthuysen; L Harris; E Lau; F W Hetzel
Journal:  Am Heart J       Date:  2001-06       Impact factor: 4.749

3.  Role of "Ischemia modified albumin", a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes.

Authors:  M K Sinha; D Roy; D C Gaze; P O Collinson; J C Kaski
Journal:  Emerg Med J       Date:  2004-01       Impact factor: 2.740

4.  Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention.

Authors:  Manas K Sinha; David C Gaze; John R Tippins; Paul O Collinson; Juan Carlos Kaski
Journal:  Circulation       Date:  2003-05-12       Impact factor: 29.690

5.  Site-specific N-terminal auto-degradation of human serum albumin.

Authors:  B Chan; N Dodsworth; J Woodrow; A Tucker; R Harris
Journal:  Eur J Biochem       Date:  1995-01-15

6.  Site-specific modification of albumin by free radicals. Reaction with copper(II) and ascorbate.

Authors:  G Marx; M Chevion
Journal:  Biochem J       Date:  1986-06-01       Impact factor: 3.857
  6 in total
  55 in total

1.  Evaluation of the Relationship Between Ischemia-Modified Albumin Levels and Thyroid Hormone Levels.

Authors:  Mufide Oncel; Aysel Kıyıcı; Serife Onen
Journal:  J Clin Lab Anal       Date:  2014-06-21       Impact factor: 2.352

2.  Assessment of oxidative, inflammatory, and fibrinolytic biomarkers and DNA strand breakage in hypercholesterolemia.

Authors:  Renata da Silva Pereira; Etiane Tatsch; Guilherme Vargas Bochi; Helena Kober; Thiago Duarte; Greice Franciele Feyh dos Santos Montagner; José Edson Paz da Silva; Marta Maria Medeiros Frescura Duarte; Ivana Beatrice Mânica da Cruz; Rafael Noal Moresco
Journal:  Inflammation       Date:  2013-08       Impact factor: 4.092

3.  Increased Oxidatively Modified Forms of Albumin in Association with Decreased Total Antioxidant Activity in Different Types of Hypertensive Disorders of Pregnancy.

Authors:  Jyothi M P D'souza; Sindhu Harish; Vinitha Ramanath Pai; Chitra Shriyan
Journal:  Indian J Clin Biochem       Date:  2016-06-07

4.  Ischemia-modified albumin levels in patients with end-stage renal disease patients on hemodialysis: does albumin analysis method affect albumin-adjusted ischemia-modified albumin levels?

Authors:  Aysel Kiyici; Idris Mehmetoğlu; Hatice Karaoğlan; Hüseyin Atalay; Yalçin Solak; Süleyman Türk
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

5.  Obstructive sleep apnea and the effect of CPAP treatment on ischemia-modified albumin levels: a multi effect size meta-analysis with diagnostic test accuracy.

Authors:  Seshadri Reddy Varikasuvu; Naveen Dutt; Dibakar Sahu
Journal:  Sleep Breath       Date:  2018-06-14       Impact factor: 2.816

Review 6.  Intramyocardial haemorrhage after acute myocardial infarction.

Authors:  Ryanne P Betgem; Guus A de Waard; Robin Nijveldt; Aernout M Beek; Javier Escaned; Niels van Royen
Journal:  Nat Rev Cardiol       Date:  2014-11-18       Impact factor: 32.419

7.  Ischemia-modified albumin as a marker of vascular dysfunction and subclinical atherosclerosis in β-thalassemia major.

Authors:  Amira Abdel Moneam Adly; Nayera Hazaa Khalil ElSherif; Eman Abdel Rahman Ismail; Yosra Abdelzaher Ibrahim; Gamal Niazi; Sara Hamed Elmetwally
Journal:  Redox Rep       Date:  2017-03-13       Impact factor: 4.412

8.  Ischemic heart diseases in Egypt: role of xanthine oxidase system and ischemia-modified albumin.

Authors:  Ola Sayed Ali; Hanan Muhammad Abdelgawad; Makram Sayed Mohammed; Rehab Refaat El-Awady
Journal:  Heart Vessels       Date:  2013-10-04       Impact factor: 2.037

9.  Evaluation of ischemia-modified albumin in anemia associated to chronic kidney disease.

Authors:  Luiz Carlos Cichota; Rafael Noal Moresco; Marta Maria Medeiros Frescura Duarte; José Edson Paz da Silva
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

10.  Estimation of Ischemia Modified Albumin (IMA) Levels in Patients with Acute Coronary Syndrome.

Authors:  Prema Gurumurthy; Sai Krishna Borra; Rama Krishna Reddy Yeruva; Dolice Victor; Sai Babu; K M Cherian
Journal:  Indian J Clin Biochem       Date:  2013-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.